NO923040D0 - Nye drivgasser, samt anvendelse i legemiddelpreparater - Google Patents

Nye drivgasser, samt anvendelse i legemiddelpreparater

Info

Publication number
NO923040D0
NO923040D0 NO1992923040A NO923040A NO923040D0 NO 923040 D0 NO923040 D0 NO 923040D0 NO 1992923040 A NO1992923040 A NO 1992923040A NO 923040 A NO923040 A NO 923040A NO 923040 D0 NO923040 D0 NO 923040D0
Authority
NO
Norway
Prior art keywords
pharmaceutical preparations
new fuel
fuel gases
gases
tgh
Prior art date
Application number
NO1992923040A
Other languages
English (en)
Other versions
NO923040L (no
NO302420B1 (no
Inventor
Hans-Hermann Weil
Ottfried Daab
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6399399&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO923040(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of NO923040D0 publication Critical patent/NO923040D0/no
Publication of NO923040L publication Critical patent/NO923040L/no
Publication of NO302420B1 publication Critical patent/NO302420B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • A61K9/124Aerosols; Foams characterised by the propellant
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K3/00Materials not provided for elsewhere
    • C09K3/30Materials not provided for elsewhere for aerosols

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO923040A 1990-02-03 1992-07-31 Legemiddelsuspensjoner i flytendegjorte drivgasser for dannelse av inhaleringsaerosoler, samt anvendelse av 1,1,1,2,3,3,3-heptafluorpropan som drivmiddel NO302420B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4003270A DE4003270A1 (de) 1990-02-03 1990-02-03 Neue treibgase und ihre verwendung in arzneimittelzubereitungen
PCT/EP1991/000178 WO1991011496A1 (de) 1990-02-03 1991-01-31 Neue treibgase und ihre verwendung in arzneimittelzubereitungen

Publications (3)

Publication Number Publication Date
NO923040D0 true NO923040D0 (no) 1992-07-31
NO923040L NO923040L (no) 1992-07-31
NO302420B1 NO302420B1 (no) 1998-03-02

Family

ID=6399399

Family Applications (1)

Application Number Title Priority Date Filing Date
NO923040A NO302420B1 (no) 1990-02-03 1992-07-31 Legemiddelsuspensjoner i flytendegjorte drivgasser for dannelse av inhaleringsaerosoler, samt anvendelse av 1,1,1,2,3,3,3-heptafluorpropan som drivmiddel

Country Status (26)

Country Link
US (7) US6419899B1 (no)
EP (1) EP0513099B1 (no)
JP (1) JP3497162B2 (no)
KR (1) KR920703034A (no)
AT (1) ATE185587T1 (no)
AU (1) AU656129B2 (no)
CA (1) CA2075060C (no)
CZ (1) CZ285209B6 (no)
DE (2) DE4003270A1 (no)
DK (1) DK0513099T3 (no)
ES (1) ES2139574T3 (no)
FI (1) FI103348B1 (no)
GR (1) GR3032176T3 (no)
HK (1) HK1010737A1 (no)
HR (1) HRP940737B1 (no)
HU (1) HU218664B (no)
IL (1) IL97024A0 (no)
NO (1) NO302420B1 (no)
NZ (1) NZ236974A (no)
PT (1) PT96635B (no)
RU (1) RU2118170C1 (no)
SI (1) SI9110155B (no)
SK (1) SK281440B6 (no)
WO (1) WO1991011496A1 (no)
YU (1) YU48509B (no)
ZA (1) ZA91756B (no)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4003270A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
MX9203481A (es) * 1990-10-18 1992-07-01 Minnesota Mining & Mfg Formulaciones.
DK0553298T3 (da) * 1990-10-18 1995-04-18 Minnesota Mining & Mfg Aerosolformulering omfattende beclomethason-17,21-dipropionat
EP0656206B1 (en) * 1991-06-10 2001-08-08 Schering Corporation Non-chlorofluorocarbon aerosol formulations
US5221492A (en) * 1991-08-23 1993-06-22 E. I. Du Pont De Nemours And Company Azeotropic mixture of perfluoropropane and dimethyl ether
GB9118830D0 (en) * 1991-09-03 1991-10-16 Minnesota Mining & Mfg Medical aerosol formulations
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
US5683676A (en) * 1991-12-12 1997-11-04 Glaxo Group Limited Canister containing aerosol formulations containing P134a and particulate medicaments
US5916540A (en) * 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
ES2079210T3 (es) * 1991-12-12 1996-01-01 Glaxo Group Ltd Formulacion farmaceutica de aerosol.
CA2125666C (en) 1991-12-12 2002-07-16 Rachel Ann Akehurst Medicaments
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
PT1086688E (pt) * 1991-12-18 2004-06-30 Minnesota Mining & Mfg Formulacoes de aerossol em suspensao
US20030103907A1 (en) * 1991-12-18 2003-06-05 Schultz Robert K. Suspension aerosol formulations
US7105152B1 (en) 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
AU3936293A (en) * 1992-03-26 1993-10-21 Great Lakes Chemical Corporation Azeotrope-like compositions of 1,1,1,2,3,3,3-heptafluoropropane and 1,1-difluoroethane
DE69324161T2 (de) * 1992-12-09 1999-10-28 Boehringer Ingelheim Pharma Stabilisierte medizinische aerosollösungen
WO1995017195A1 (en) * 1993-12-20 1995-06-29 Minnesota Mining And Manufacturing Company Flunisolide aerosol formulations
CZ288146B6 (en) 1994-12-22 2001-05-16 Astra Ab Pharmaceutical aerosol preparation, process of its preparation and use
US6135628A (en) * 1995-10-13 2000-10-24 Boehringer Ingelheim Pharmceuticals, Inc. Method and apparatus for homogenizing aerosol formulations
US6054488A (en) * 1996-06-11 2000-04-25 3M Innovative Properties Company Medicinal aerosol formulations of formoterol
US6039932A (en) * 1996-09-27 2000-03-21 3M Innovative Properties Company Medicinal inhalation aerosol formulations containing budesonide
DE19652790A1 (de) * 1996-12-18 1998-06-25 Hermes Fabrik Pharm Praeparate Pharmazeutische Zubereitungen
US6235265B1 (en) * 1998-10-28 2001-05-22 Alliedsignal Inc. Evaporative coolant for topical anesthesia comprising hydrofluorocarbons and/or hydrochlorofluorocarbons
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
DE10050994A1 (de) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
US6706726B2 (en) 2000-10-14 2004-03-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics which may be used as medicaments as well as processes for preparing them
DE10062712A1 (de) * 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
US7754242B2 (en) * 2002-03-20 2010-07-13 Alkermes, Inc. Inhalable sustained therapeutic formulations
US7582284B2 (en) * 2002-04-17 2009-09-01 Nektar Therapeutics Particulate materials
US7273603B2 (en) 2003-07-11 2007-09-25 Boehringer Ingelheim International Gmbh HFC solution formulations containing an anticholinergic
SG147453A1 (en) * 2003-10-20 2008-11-28 Schering Corp Pharmaceutical aerosol compositions
WO2006002840A2 (de) * 2004-07-02 2006-01-12 Boehringer Ingelheim International Gmbh Aerosolsuspensionsformulierungen mit tg 227 ea oder tg 134 a als treibmittel
JP2008538758A (ja) * 2005-04-23 2008-11-06 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 抗コリン作用薬に加えてベータ受容体刺激薬及びステロイドを含有する吸入用の医薬組成物
DE102006017320A1 (de) * 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
DK2120875T3 (en) 2007-02-11 2018-10-22 Map Pharmaceuticals Inc METHOD OF THERAPEUTIC ADMINISTRATION OF DHE TO POSSIBLE QUICK PREVENTION OF MIGRANE AT THE MINIMUM OF THE SIDE EFFECT PROFILE
EP2282418A3 (en) 2009-06-23 2011-03-09 Alcatel Lucent A station comprising at least two transmit antennas, and a method of transmitting therefrom
CA2895816C (en) 2012-12-21 2021-02-23 Map Pharmaceuticals, Inc. 8'-hydroxy-dihydroergotamine compounds and compositions

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2490764A (en) * 1945-07-04 1949-12-13 Kinetic Chemicals Inc Fluorinated organic compounds
BE555319A (no) * 1956-03-21 1900-01-01
BE556587A (no) * 1957-01-31 1957-04-11
GB902590A (en) 1960-03-22 1962-08-01 Allied Chem Production of heptafluoropropane
US3095355A (en) * 1961-10-12 1963-06-25 Revlon Aerosol composition
NL289785A (no) * 1962-11-29
DE1542076A1 (de) * 1966-04-21 1970-03-26 Colgate Palmolive Co Aerosol-Treibmittel
US3369913A (en) * 1967-03-20 1968-02-20 Union Carbide Corp Self-propelling food mixture
DE1719443B2 (de) 1967-10-07 1973-04-05 Suspensions-aerosole und verfahren zu ihrer herstellung
US4044126A (en) * 1972-04-20 1977-08-23 Allen & Hanburys Limited Steroidal aerosol compositions and process for the preparation thereof
FI770215A (no) 1976-01-30 1977-07-31 Fisons Ltd
NL7708731A (nl) * 1976-08-13 1978-02-15 Montedison Spa Werkwijze voor de bereiding van nieuwe drijf- middelsamenstellingen voor aerosolen.
US4174795A (en) * 1977-02-14 1979-11-20 Bohm Leslie E Pannier mounting arrangement for cycles
GB2001334B (en) 1977-07-19 1982-03-03 Fisons Ltd Pressurised aerosol formulation
CA1136547A (en) 1979-03-08 1982-11-30 Song-Ling Lin Aerosol anesthetic compositions
JPS55131096A (en) 1979-03-30 1980-10-11 Daikin Ind Ltd Working fluid for rankine cycle
US4352789A (en) 1980-03-17 1982-10-05 Minnesota Mining And Manufacturing Company Aerosol compositions containing finely divided solid materials
DE3160797D1 (en) * 1980-07-16 1983-09-29 Glaxo Group Ltd 11-alpha-amino androstanes, pharmaceutical compositions containing them and processes for their preparation
GB8432063D0 (en) * 1984-12-19 1985-01-30 Riker Laboratories Inc Physically modified steroids
GB8501015D0 (en) * 1985-01-16 1985-02-20 Riker Laboratories Inc Drug
US4778674A (en) * 1986-05-28 1988-10-18 Richardson-Vicks Inc. Dry aerosol foam
DE3735467A1 (de) 1987-10-20 1989-05-03 Bayer Ag Verfahren zur herstellung von fluorierten c(pfeil abwaerts)4(pfeil abwaerts)- bis c(pfeil abwaerts)6(pfeil abwaerts)-kohlenwasserstoffen und neue cyclische fluorierte kohlenwasserstoffe, sowie die verwendung von fluorierten c(pfeil abwaerts)4(pfeil abwaerts)- bis c(pfeil abwaerts)6(pfeil abwaerts)-kohlenwasserstoffen als treibgas und arbeitsfluessigkeit fuer waermepumpensysteme
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
DE3903336A1 (de) 1989-02-04 1990-08-09 Bayer Ag Verwendung von c(pfeil abwaerts)3(pfeil abwaerts)- bis c(pfeil abwaerts)5(pfeil abwaerts)-polyfluoralkanen als treibgase
DE3905726A1 (de) * 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
JP2642738B2 (ja) 1989-04-13 1997-08-20 ライオン株式会社 人体塗布用エアゾール製品
DE4003270A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
IL97065A (en) 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
DE4003272A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
US5118494A (en) * 1990-03-23 1992-06-02 Minnesota Mining And Manufacturing Company Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
US5182097A (en) * 1991-02-14 1993-01-26 Virginia Commonwealth University Formulations for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
EP0504112A3 (en) 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
EP0656206B1 (en) 1991-06-10 2001-08-08 Schering Corporation Non-chlorofluorocarbon aerosol formulations
NZ243062A (en) 1991-06-10 1993-09-27 Schering Corp Aerosol containing medicament and 1,1,1,2-tetrafluoroethane
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
US5683676A (en) * 1991-12-12 1997-11-04 Glaxo Group Limited Canister containing aerosol formulations containing P134a and particulate medicaments
DK0550031T3 (da) 1991-12-31 1996-08-26 Solvay Medicinsk aerosolformulering
GB9425160D0 (en) * 1994-12-10 1995-02-08 Glaxo Group Ltd Medicaments
CZ288146B6 (en) 1994-12-22 2001-05-16 Astra Ab Pharmaceutical aerosol preparation, process of its preparation and use
TR199701170T1 (xx) * 1995-04-14 1998-02-21 Glaxo Wellcome Inc. Beklometazon dipropionat i�in �l��lm�� doz inhaleri.
US6461591B1 (en) 1997-02-05 2002-10-08 Jago Research Ag Medical aerosol formulations
US5891420A (en) * 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe triancinolone acetonide aerosol formulations for oral inhalation

Also Published As

Publication number Publication date
US20040028618A1 (en) 2004-02-12
EP0513099A1 (de) 1992-11-19
US20050031548A1 (en) 2005-02-10
HK1010737A1 (en) 1999-06-25
US20090104127A1 (en) 2009-04-23
HU9202508D0 (en) 1992-10-28
JP3497162B2 (ja) 2004-02-16
CA2075060C (en) 2001-01-02
AU7211691A (en) 1991-08-21
RU2118170C1 (ru) 1998-08-27
US20110014134A1 (en) 2011-01-20
ZA91756B (en) 1992-10-28
PT96635A (pt) 1991-10-31
PT96635B (pt) 1998-07-31
US20020071812A1 (en) 2002-06-13
WO1991011496A1 (de) 1991-08-08
DE59109161D1 (de) 1999-11-18
US20070065370A1 (en) 2007-03-22
IL97024A0 (en) 1992-03-29
US7160538B2 (en) 2007-01-09
ATE185587T1 (de) 1999-10-15
EP0513099B1 (de) 1999-10-13
HRP940737B1 (en) 2000-10-31
US6419899B1 (en) 2002-07-16
NO923040L (no) 1992-07-31
SI9110155A (sl) 1998-04-30
HUT62455A (en) 1993-05-28
CS9100265A2 (en) 1991-09-15
KR920703034A (ko) 1992-12-17
SI9110155B (sl) 1999-06-30
YU48509B (sh) 1998-09-18
NO302420B1 (no) 1998-03-02
FI923491A0 (fi) 1992-08-03
CZ285209B6 (cs) 1999-06-16
ES2139574T3 (es) 2000-02-16
HRP940737A2 (en) 1997-06-30
NZ236974A (en) 1993-07-27
GR3032176T3 (en) 2000-04-27
CA2075060A1 (en) 1991-08-04
FI103348B (fi) 1999-06-15
YU15591A (sh) 1994-01-20
FI103348B1 (fi) 1999-06-15
FI923491A (fi) 1992-08-03
SK281440B6 (sk) 2001-03-12
DK0513099T3 (da) 2000-04-10
AU656129B2 (en) 1995-01-27
DE4003270A1 (de) 1991-08-08
HU218664B (hu) 2000-10-28
JPH05504350A (ja) 1993-07-08

Similar Documents

Publication Publication Date Title
NO923040D0 (no) Nye drivgasser, samt anvendelse i legemiddelpreparater
TR199901361T2 (xx) S�lfonamid t�revleri, haz�rlanma prosesi ve ila� olarak kullan�mlar�
DE68924202T2 (de) Überschall-Kraftstoff-Einspritzdüse.
DE58900941D1 (de) Verwendung von 1,1,1,4,4,4-hexafluorbutan als treib- und daemmgas fuer die herstellung von kunststoff-schaumstoffen.
DK0807178T3 (da) Mycobaktielle proteiner, mikroorganismer producerende samme og anvendelser af nævnte proteiner i vacciner og til påvisning af tuberkulose
DE69103055T2 (de) Zweistufiger Joule-Thomson-Kryostat mit Gaszufuhrsteuerungssystem und dessen Verwendungen.
DE68912668T2 (de) Gasbrennkraftmaschine und Brennstoffzufuhrsystem.
DE68919101T2 (de) Gasabschaltungsvorrichtung.
FR2652426B1 (fr) Detendeur de bouteille de gaz.
DK0439846T4 (da) Biologisk nedbrydelige polymerer, fremgangsmåde til deres fremstilling samt deres anvendelse til depotpræparater med regule
DK0605483T3 (da) Drivmiddel for aerosoler og doseringsaerosoler
ES2093528T3 (es) Composiciones que incluyen un hexafluoropropano.
DE68908880T2 (de) Äthanolbrennstoff und dessen verwendung als dieselbrennstoff.
FI960839A0 (fi) Uusia tripeptidejä, jotka ovat käyttökelpoisia immuuni- ja CNS-terapiassa
Buckmaster et al. Radial Propagation of Premixed Flames and v/t Behavior
廖晓昕 et al. Stability of Hopfield-type neural networks Ⅱ
KR900003091U (ko) 액화가스(lpg, cng) 분사기
KR950006848U (ko) 부탄, 프로판 겸용 가스레인지
Landis Novel propellants derived from atmospheric CO 2 on Mars
GRATTON et al. Alternate fuels combustion research[Final Report, May 1980- Sep. 1983]
NO903670D0 (no) Etanoldrivstoff, samt anvendelse av dette som dieseldrivstoff.
KR910011936U (ko) 가스버너의 중앙공기 및 연료분사장치
NO910602D0 (no) Nye cytidin-5'-difosfatalkanoler og -glyceroler, en fremgangsmaate til deres fremstilling samt deres anvendelse.
NO911394D0 (no) Polystyren/polyisopren/polystyren-blokk-kopolymerer, varmesmelte-klebemiddelblandinger, samt artikler produsert av dem.
GB1250122A (no)

Legal Events

Date Code Title Description
MK1K Patent expired